Spontaneous regression of intermediate-grade non-Hodgkin's lymphoma

被引：1
|
作者：
Rappaport, DC
Haider, MA
Sternthal, E
机构：
[1] Univ Toronto, Princess Margaret Hosp, Dept Med Imaging, Toronto, ON M5G 2C4, Canada
[2] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 2C4, Canada
[3] Univ Toronto, Toronto Hosp, Dept Surg, Toronto, ON M5G 2C4, Canada
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 1999年 / 172卷 / 01期
关键词：
D O I：
10.2214/ajr.172.1.9888753
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：131 / 133
页数：3
相关论文
共 50 条
  • [21] Daunoxome in the treatment of relapsed/refractory low grade and intermediate grade non-Hodgkin's lymphoma (NHL)
    Tulpule, A
    Rarick, MU
    Kolitz, J
    Bernstein, J
    HarveyBuchanan, L
    Espina, BM
    Trader, G
    Mukwaya, G
    Onetto, N
    Gill, PS
    Levine, AM
    BLOOD, 1997, 90 (10) : 846 - 846
  • [22] Transient spontaneous regression of aggressive non-Hodgkin's lymphoma confined to the adrenal glands
    T. Fujiwara
    M. Kawamura
    A. Sasaki
    H. Asahi
    S. Sasou
    S. Itoh
    K. Hiramori
    Annals of Hematology, 2001, 80 : 561 - 564
  • [23] Spontaneous regression of non-Hodgkin's lymphoma in the oral cavity after incisional biopsy
    Daly, R. -M.
    Healy, C. M.
    Toner, M. E.
    Flint, S. R.
    BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2008, 46 (03): : 223 - 225
  • [24] Transient spontaneous regression of aggressive non-Hodgkin's lymphoma confined to the adrenal glands
    Fujiwara, T
    Kawamura, M
    Sasaki, A
    Asahi, H
    Sasou, S
    Itoh, S
    Hiramori, K
    ANNALS OF HEMATOLOGY, 2001, 80 (09) : 561 - 564
  • [25] Neutron and photon clonogenic survival curves of two chemotherapy resistant human intermediate-grade non-Hodgkin lymphoma cell lines
    Aref, A
    Yudelev, M
    Mohammad, R
    Choudhuri, R
    Orton, C
    Al-Katib, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (04): : 999 - 1003
  • [26] COMBINED SURGERY AND CHEMOTHERAPY FOR THE TREATMENT OF PRIMARY GASTROINTESTINAL INTERMEDIATE-GRADE OR HIGH-GRADE NON-HODGKIN LYMPHOMAS
    BELLESI, G
    ALTERINI, R
    MESSORI, A
    BOSI, A
    BERNARDI, F
    DILOLLO, S
    FERRINI, PR
    BRITISH JOURNAL OF CANCER, 1989, 60 (02) : 244 - 248
  • [27] PRIMARY CHEMOTHERAPY FOR OBSTRUCTIVE-JAUNDICE CAUSED BY INTERMEDIATE-GRADE NON-HODGKIN-LYMPHOMA
    MEISENBERG, B
    CANCER, 1993, 72 (11) : 3368 - 3368
  • [28] Risk and timing of hospitalization for febrile neutropenia among patients receiving CHOP-like regimens for intermediate-grade non-Hodgkin's lymphoma.
    Lyman, GH
    Delgado, DJ
    BLOOD, 2002, 100 (11) : 780A - 780A
  • [29] Intrathecal chemotherapy is ineffective for central nervous system (CNS) prophylaxis in patients with high-risk intermediate-grade non-Hodgkin's lymphoma (NHL).
    Chua, SL
    Seymour, JF
    Streater, J
    Wolf, MM
    Januszewicz, EH
    Prince, HM
    BLOOD, 2000, 96 (11) : 728A - 728A
  • [30] A new protocol (MiCEP) for the treatment of intermediate or high grade non-Hodgkin's lymphoma in the elderly
    Bellesi, G
    Rigacci, L
    Alterini, R
    Bernardi, F
    Stefanacci, S
    Innocenti, F
    Longo, G
    diLollo, S
    Ferrini, PR
    BLOOD, 1995, 86 (10) : 3221 - 3221
12345